About Allergan EyeCare

Allergan plc headquartered in Dublin, Ireland, is a unique, global pharmaceutical company focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.

A leader in eye care, Allergan has been developing best-in-class ophthalmic products since 1950. Our portfolio comprises more than 80 products to treat diseases such as glaucoma, ocular surface diseases, retinal diseases, allergy, inflammation and ocular infection. Many of these products are the leading brands in the specific therapeutic area, reflecting Allergan’s global leadership position in eye care. Allergan is committed to providing innovative treatments that help patients see better and make a real difference in the fight against preventable blindness.

About Bausch + Lomb

Bausch + Lomb is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Our core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.

About Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2016, the Group achieved net sales of USD 48.5 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.

For more information, please visit http://www.novartis.com